- Report
- November 2025
- 150 Pages
India
From €4257EUR$4,850USD£3,682GBP
- Report
- November 2025
- 150 Pages
Japan
From €4257EUR$4,850USD£3,682GBP
- Report
- November 2025
- 150 Pages
Japan
From €4257EUR$4,850USD£3,682GBP
- Report
- November 2025
- 150 Pages
China
From €4257EUR$4,850USD£3,682GBP
- Report
- November 2025
- 150 Pages
China
From €4257EUR$4,850USD£3,682GBP
- Report
- October 2025
- 150 Pages
Germany
From €4257EUR$4,850USD£3,682GBP
- Report
- September 2025
- 150 Pages
China
From €4257EUR$4,850USD£3,682GBP
- Report
- September 2025
- 150 Pages
Canada
From €4257EUR$4,850USD£3,682GBP
- Report
- April 2025
- 150 Pages
Global
From €4257EUR$4,850USD£3,682GBP
- Report
- March 2025
- 150 Pages
Global
From €4257EUR$4,850USD£3,682GBP
- Report
- March 2025
- 150 Pages
Global
From €4257EUR$4,850USD£3,682GBP
- Report
- February 2025
- 150 Pages
Global
From €4257EUR$4,850USD£3,682GBP
- Report
- February 2025
- 150 Pages
Global
From €4257EUR$4,850USD£3,682GBP
- Report
- February 2025
- 150 Pages
Global
From €4257EUR$4,850USD£3,682GBP
- Report
- December 2024
- 150 Pages
Global
From €4257EUR$4,850USD£3,682GBP
- Report
- January 2024
- 150 Pages
Global
From €4257EUR$4,850USD£3,682GBP
- Report
- November 2023
- 150 Pages
Global
From €4257EUR$4,850USD£3,682GBP
- Report
- January 2025
- 87 Pages
Global
From €3500EUR$4,272USD£3,133GBP
- Report
- January 2025
- 93 Pages
Europe
From €3028EUR$3,450USD£2,619GBP
- Report
- January 2025
- 73 Pages
Middle East, Africa
From €3028EUR$3,450USD£2,619GBP

The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products.
The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more